Gladstone’s community continues efforts to support and address the diverse, unique, and complex needs of women in the organization.
Yu Zhang, a postdoctoral scholar at Gladstone, shares how training at Gladstone has benefitted her both professionally and personally.
By identifying the role of common cells in connective tissue, Gladstone scientists discovered a new target to fight transmission of the virus.
Katherine Pollard, PhD, director of the convergence science initiative at the Gladstone Institutes, has been selected as a Chan Zuckerberg Investigator.
A trio of Gladstone scientists are studying the basic biology of the heart to guide the discovery of new therapies for conditions such as congenital heart disease and heart failure.
Bay Area philanthropist leaves a legacy as a long-time friend and supporter of the Gladstone Institutes.
Bay Area scientists gathered to learn about the latest advances in mass spectrometry.
Gladstone scientists are mapping the connections and functions of brain cells to identify new drug targets to treat psychiatric disorders.
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
Thomas Packard, a postdoctoral scholar at Gladstone, talks about his life-long passion for science and how Gladstone's reputation as a top place to do a postdoctoral fellowship led him to the Greene laboratory.
Anti-cancer drug prevented less weight gain and caused mice to burn more calories thanks to higher levels of metabolism-boosting brown fat.
Gladstone hosted a reception for attendees of the 35th annual J.P. Morgan Healthcare Conference to discuss scientific discoveries, partnering opportunities, and investment strategies involving Gladstone’s research.
Scientists discover an enzyme that that could be targeted to treat both Alzheimer’s disease and frontotemporal dementia.
Scientists from the Gladstone Institutes will team up with other national experts to better understand frontotemporal dementia.
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson’s, Huntington’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).
Chris Goodfellow shares how his love of motorcycles has influenced his path to Gladstone and fueled his passion for traveling.
Research on a gene mutation that causes holes in the hearts of infants revealed insights into how the heart develops and how it stays healthy.
Katherine Pollard’s expertise, success, and vision fueled her promotion to director of Gladstone’s Convergence Zone.
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
Anatol Kreitzer was unanimously selected based on his experience training graduate students and his vision for the future.
Jennifer Doudna, PhD, was recognized for pioneering technology that transformed gene editing and revolutionized biomedical research.
Meredith Calvert shares how her family history and her passions for art and biology led her to a career in microscopy.
Yen-Sin Ang, PhD, a research scientist at the Gladstone Institutes, was awarded the Louis N. and Arnold M.
In a meeting of the minds, Gladstone hosted a national behavioral neuroscience symposium to share scientific breakthroughs and compare research methods.
The delayed antiviral immune response allows the virus to remain undetected in the vagina, which can increase the risk of fetal infection during pregnancy.